Kromek awarded $1.8m funding from DTRA

Kromek (AIM: KMK), a radiation detection technology company focusing on the medical, security and nuclear markets, announced on September 27th that it has been awarded a contract by the US Defense Threat Reduction Agency (“DTRA”), an agency of the US Department of Defense, under a previously announced agreement, to develop a next-generation Radionuclide Identification Device to meet future military operational challenges. The funding, which totals $1.8 million, will be delivered over the two-year project period.

Under the terms of the contract, Kromek will enhance its D3S platform to develop a next-generation, ruggedised small form factor for use in the military field. By using advanced detector materials, the device will generate higher resolution detection and superior localisation and identification of radioactive material for use by the US military in combat environments.

Dr Arnab Basu, CEO of Kromek, commented: “We are seeing considerable traction for our D3S radiation detectors as they continue to prove their efficacy in the security markets globally. This project with the DTRA highlights the versatility of our technology platform as we develop a ruggedised device capable of identifying radioactive threats in a military environment. Our long-term relationship with multiple agencies of the US Department of Defense is the result of a shared commitment to develop next-generation technology and we look forward to continuing this work with the DTRA.”

Our Current Sponsors